dHealthIQ vs CellPoint Usage & Stats

When it comes to your health, one size does not fit all. It is no shock to hear that we all have a different metabolic system. But then why do we turn to standard treatments for every chronic patient in our care system today? The dHealthIQ app is based on the assumption that all people are best served with a personalized treatment plan. Our mobile application is part of a digital disease management system provided through the primary care system. The application makes use of the unique health metrics and data of each participant, applying artificial intelligence (AI) to analyse health data. The dHealthIQ app provides you with - Real-time alerts based on changes in your health data; - Insights in your health data; - Communication tools between you and your primary caretaker or doctor; - Tasks and reminders within a prescribed treatment plan - Receive targeted educational materials to effectively manage your illness - Convenient (smart) device connectivity and manual data input options We update the dHealthIQ app regularly so its serves your needs in the best way possible. In the near future we will extent the application with digital therapeutics. These therapeutics are software enabled and clinically validated treatments programs personalized for each our participants. Do you want access to the dHealthIQ app? Please ask your primary caretaker for more information or check our website https:/dhealthiq.com/. Data is processed according to the General Data Protection Regulation (GDPR). The privacy regulations and terms of use can be found in the dHealthIQ app.

Apple App Store
Free
Medical

Store Rank

- -

CellPoint

The CellPoint application has been developed for oncology patients enrolled in CellPoint CAR-T therapies at the point-of-care. The CellPoint application can be linked to the CardioWatch 287-2B bracelet. This bracelet and the application are intended for continuous monitoring of vital signs and capturing questionnaires throughout the patient’s treatment with CAR-T therapies. The CardioWatch 287-2B is a medically certified wireless remote monitoring system intended for continuous collection of vital parameters in home and in healthcare settings. CardioWatch 287 is a CE medical device certified under EU-MDR standards. Data is transmitted wirelessly from the device via the application to the health cloud where it is stored and made available for further analysis. About CellPoint CellPoint, a Galapagos company, is dedicated to developing CAR-T therapies at the point-of-care, making these therapies more affordable and accessible to patients. CellPoint has developed a rapid manufacturing process, powered by its proprietary xCellit real-time monitoring software system, that allows for 1 week vein-to-vein time compared to over one month with current industry manufacturing platforms. A first proprietary CD19 CAR-T investigational therapy is currently in Phase1/2a trials to provide fast clinical validation of the decentralized point-of-care production model. More information at www.cellpoint.bio. This application is only supported by phones with Bluetooth® 5.0 Low Energy. For Non European customers, CardioWatch 287 is available as Investigative device to collect body metrics data. The device is not used for medical diagnostic or treatment. No physical harm risk.